HIV 10 years later-where do we stand now? - 10th international AIDS meeting, Yokohama

Lung Ji Chang, Yi Ming A. Chen, Mao Yuan Chen, Chen Cheng Chou, Shiing Jer Twu, Li Min Huang

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

A wide variety of up-to-date results and knowledge were presented at the 10th International AIDS Meeting, Yokohama. Epidemiologically, most interest was focused on the discovery of a new HIV subtype O, which cannot be reliably detected by currently available ELISA kits. Clinically, it is gradually appreciated that one single most important parameter is the viral load; the extent of viral load can help explain many clinical observations. Another eye-catching finding was the report of a clinical follow-up of a group of long-term nonprogressors. If the underlying operative mechanism can be elucidated, we can learn the necessary elements for halting HIV infection progression. Therapeutically, the trend has shifted to combination therapy, preferentially 3-drug combination of 2 RT inhibitors and 1 protease inhibitor. For the vaccine development, many novel vectors were introduced, but their potentials are unknown at present. The successful application of single-cell in situ PCR has changed our perception of HIV infection. This powerful technique can detect a single viral genome inside cells and revealed that a large proportion of cells already harbor HIV genomes soon after the entry of HIV into the body. A direct viral effect may fully explain subsequent T cell depletion without invoking a lot of indirect mechanisms such as apoptosis.

Original languageEnglish
Pages (from-to)1-11
Number of pages11
JournalJournal of Biomedical Science
Volume2
Issue number1
DOIs
Publication statusPublished - Jan 1 1995
Externally publishedYes

Fingerprint

Acquired Immunodeficiency Syndrome
Genes
HIV
Viral Load
HIV Infections
T-cells
Drug Combinations
Ports and harbors
Protease Inhibitors
Vaccines
Viral Genome
Apoptosis
Enzyme-Linked Immunosorbent Assay
Genome
T-Lymphocytes
Polymerase Chain Reaction
Therapeutics
Knowledge of Results (Psychology)

Keywords

  • AIDS
  • Epidemiology
  • HIV

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Molecular Biology
  • Clinical Biochemistry
  • Cell Biology
  • Biochemistry, medical
  • Pharmacology (medical)

Cite this

HIV 10 years later-where do we stand now? - 10th international AIDS meeting, Yokohama. / Chang, Lung Ji; Chen, Yi Ming A.; Chen, Mao Yuan; Chou, Chen Cheng; Twu, Shiing Jer; Huang, Li Min.

In: Journal of Biomedical Science, Vol. 2, No. 1, 01.01.1995, p. 1-11.

Research output: Contribution to journalArticle

Chang, Lung Ji ; Chen, Yi Ming A. ; Chen, Mao Yuan ; Chou, Chen Cheng ; Twu, Shiing Jer ; Huang, Li Min. / HIV 10 years later-where do we stand now? - 10th international AIDS meeting, Yokohama. In: Journal of Biomedical Science. 1995 ; Vol. 2, No. 1. pp. 1-11.
@article{4bee90112e0141ec90ea355ef278bca8,
title = "HIV 10 years later-where do we stand now? - 10th international AIDS meeting, Yokohama",
abstract = "A wide variety of up-to-date results and knowledge were presented at the 10th International AIDS Meeting, Yokohama. Epidemiologically, most interest was focused on the discovery of a new HIV subtype O, which cannot be reliably detected by currently available ELISA kits. Clinically, it is gradually appreciated that one single most important parameter is the viral load; the extent of viral load can help explain many clinical observations. Another eye-catching finding was the report of a clinical follow-up of a group of long-term nonprogressors. If the underlying operative mechanism can be elucidated, we can learn the necessary elements for halting HIV infection progression. Therapeutically, the trend has shifted to combination therapy, preferentially 3-drug combination of 2 RT inhibitors and 1 protease inhibitor. For the vaccine development, many novel vectors were introduced, but their potentials are unknown at present. The successful application of single-cell in situ PCR has changed our perception of HIV infection. This powerful technique can detect a single viral genome inside cells and revealed that a large proportion of cells already harbor HIV genomes soon after the entry of HIV into the body. A direct viral effect may fully explain subsequent T cell depletion without invoking a lot of indirect mechanisms such as apoptosis.",
keywords = "AIDS, Epidemiology, HIV",
author = "Chang, {Lung Ji} and Chen, {Yi Ming A.} and Chen, {Mao Yuan} and Chou, {Chen Cheng} and Twu, {Shiing Jer} and Huang, {Li Min}",
year = "1995",
month = "1",
day = "1",
doi = "10.1007/BF02257919",
language = "English",
volume = "2",
pages = "1--11",
journal = "Journal of Biomedical Science",
issn = "1021-7770",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - HIV 10 years later-where do we stand now? - 10th international AIDS meeting, Yokohama

AU - Chang, Lung Ji

AU - Chen, Yi Ming A.

AU - Chen, Mao Yuan

AU - Chou, Chen Cheng

AU - Twu, Shiing Jer

AU - Huang, Li Min

PY - 1995/1/1

Y1 - 1995/1/1

N2 - A wide variety of up-to-date results and knowledge were presented at the 10th International AIDS Meeting, Yokohama. Epidemiologically, most interest was focused on the discovery of a new HIV subtype O, which cannot be reliably detected by currently available ELISA kits. Clinically, it is gradually appreciated that one single most important parameter is the viral load; the extent of viral load can help explain many clinical observations. Another eye-catching finding was the report of a clinical follow-up of a group of long-term nonprogressors. If the underlying operative mechanism can be elucidated, we can learn the necessary elements for halting HIV infection progression. Therapeutically, the trend has shifted to combination therapy, preferentially 3-drug combination of 2 RT inhibitors and 1 protease inhibitor. For the vaccine development, many novel vectors were introduced, but their potentials are unknown at present. The successful application of single-cell in situ PCR has changed our perception of HIV infection. This powerful technique can detect a single viral genome inside cells and revealed that a large proportion of cells already harbor HIV genomes soon after the entry of HIV into the body. A direct viral effect may fully explain subsequent T cell depletion without invoking a lot of indirect mechanisms such as apoptosis.

AB - A wide variety of up-to-date results and knowledge were presented at the 10th International AIDS Meeting, Yokohama. Epidemiologically, most interest was focused on the discovery of a new HIV subtype O, which cannot be reliably detected by currently available ELISA kits. Clinically, it is gradually appreciated that one single most important parameter is the viral load; the extent of viral load can help explain many clinical observations. Another eye-catching finding was the report of a clinical follow-up of a group of long-term nonprogressors. If the underlying operative mechanism can be elucidated, we can learn the necessary elements for halting HIV infection progression. Therapeutically, the trend has shifted to combination therapy, preferentially 3-drug combination of 2 RT inhibitors and 1 protease inhibitor. For the vaccine development, many novel vectors were introduced, but their potentials are unknown at present. The successful application of single-cell in situ PCR has changed our perception of HIV infection. This powerful technique can detect a single viral genome inside cells and revealed that a large proportion of cells already harbor HIV genomes soon after the entry of HIV into the body. A direct viral effect may fully explain subsequent T cell depletion without invoking a lot of indirect mechanisms such as apoptosis.

KW - AIDS

KW - Epidemiology

KW - HIV

UR - http://www.scopus.com/inward/record.url?scp=34249757480&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34249757480&partnerID=8YFLogxK

U2 - 10.1007/BF02257919

DO - 10.1007/BF02257919

M3 - Article

AN - SCOPUS:34249757480

VL - 2

SP - 1

EP - 11

JO - Journal of Biomedical Science

JF - Journal of Biomedical Science

SN - 1021-7770

IS - 1

ER -